Aims and Scope of Expert Review of Pharmacoeconomics and Outcomes Research
Expert Review of Pharmacoeconomics & Outcomes Research is a bimonthly peer-reviewed medical journal covering all aspects of pharmacoeconomics. It was established in 2001 and is published by Informa. The editor-in-chief is A. Bottomley (European Organisation for Research and Treatment of Cancer). Less
Key Metrics
CiteScore 

3.4
H-Index 

60
Impact Factor 

< 5
SJR 

Q2Health Policy

SNIP 

0.9
Recommended pre-submission checks
Powered by 

Topics Covered on Expert Review of Pharmacoeconomics and Outcomes Research
Expert Review of Pharmacoeconomics and Outcomes Research Journal Specifications
| Overview | |
| Publisher | TAYLOR & FRANCIS LTD |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 2001 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Expert Review of Pharmacoeconomics and Outcomes Research ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Expert Review of Pharmacoeconomics and Outcomes Research
Universal school-based mental health promotion in Vietnam: a critical appraisal of a health-economic evaluation
- 9 Aug 2026
- Expert Review of Pharmacoeconomics & Outcomes Research
Comparative landscape of artificial intelligence-assisted systematic literature reviews
- 9 Aug 2026
- Expert Review of Pharmacoeconomics & Outcomes Research
Single versus multiple inhaler triple therapy in COPD using data from the pragmatic INTREPID trial: cost-effectiveness analysis from the Chilean public healthcare system perspective
- 9 Aug 2026
- Expert Review of Pharmacoeconomics & Outcomes Research
The economic burden of MASH: comparison of healthcare resource utilization and costs in patients with probable MASH, without MASH, and with diagnosed MASH.
- 30 Jun 2026
- Expert review of pharmacoeconomics & outcomes research
TENS in chronic pain management: a 11-year nationwide analysis using the French National Health Data System
- 27 Jun 2026
- Expert Review of Pharmacoeconomics & Outcomes Research
Real-world direct medical costs and resource utilization of immune checkpoint inhibitors in advanced NSCLC with COPD: a multicenter cost-consequence analysis from Iraq
- 27 Jun 2026
- Expert Review of Pharmacoeconomics & Outcomes Research
Universal school-based mental health promotion in Vietnam: a critical appraisal of a health-economic evaluation
- 9 Aug 2026
- Expert Review of Pharmacoeconomics & Outcomes Research
Comparative landscape of artificial intelligence-assisted systematic literature reviews
- 9 Aug 2026
- Expert Review of Pharmacoeconomics & Outcomes Research
Single versus multiple inhaler triple therapy in COPD using data from the pragmatic INTREPID trial: cost-effectiveness analysis from the Chilean public healthcare system perspective
- 9 Aug 2026
- Expert Review of Pharmacoeconomics & Outcomes Research
The economic burden of MASH: comparison of healthcare resource utilization and costs in patients with probable MASH, without MASH, and with diagnosed MASH.
- 30 Jun 2026
- Expert review of pharmacoeconomics & outcomes research
TENS in chronic pain management: a 11-year nationwide analysis using the French National Health Data System
- 27 Jun 2026
- Expert Review of Pharmacoeconomics & Outcomes Research
Real-world direct medical costs and resource utilization of immune checkpoint inhibitors in advanced NSCLC with COPD: a multicenter cost-consequence analysis from Iraq
- 27 Jun 2026
- Expert Review of Pharmacoeconomics & Outcomes Research